Evidence map›Paper›PMID 25766536›Full record

Observational studyJournal of the American Society of Nephrology : JASN2015

Risk of Adverse Pregnancy Outcomes in Women with CKD.

Giorgina Barbara Piccoli, Gianfranca Cabiddu, Rossella Attini, Federica Neve Vigotti, Stefania Maxia, Nicola Lepori, Milena Tuveri, Marco Massidda, Cecilia Marchi, Silvia Mura and 8 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Society of Nephrology : JASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 9 pooled it
37.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 9 syntheses or guidelines pooled it, 340 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Kidney biopsy guidebook 2020 in Japan.Clinical and experimental nephrology · 2021
    Guideline
  6. Pooled it
  7. Guideline
  8. Guideline
  9. Guideline
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Giorgina Barbara PiccoliDivision of Nephrology, Department of Clinical and Biological Sciences, and giorgina.piccoli@unito.it.
Gianfranca CabidduDepartments of Nephrology.
Rossella AttiniDivisions of Obstetrics and.
Federica Neve VigottiDivision of Nephrology, Department of Clinical and Biological Sciences, and.
Stefania MaxiaDepartments of Nephrology.
Nicola LeporiDepartments of Nephrology.
Milena TuveriObstetrics and Gynecology, and.
Marco MassiddaObstetrics and Gynecology, and.
Cecilia MarchiObstetrics and Gynecology, and.
Silvia MuraObstetrics and Gynecology, and.
Alessandra CosciaNeonatology, Department of Surgical Sciences, University of Torino, Torino, Italy;
Marilisa BiolcatiDivisions of Obstetrics and.
Pietro GagliotiDivisions of Obstetrics and.
Michele NichelattiBiostatistics Service, Department of Hematology, Niguarda Ca' Granda Hospital, Milan, Italy.
Luciana PibiriNeonatology, Brotzu Hospital, Cagliari, Italy; and.
Giuseppe ChessaObstetrics and Gynecology, and.
Antonello PaniDepartments of Nephrology.
Tullia TodrosDivisions of Obstetrics and.
University of Turin · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CKD is increasingly prevalent in pregnancy. In the Torino-Cagliari Observational Study (TOCOS), we assessed whether the risk for adverse pregnancy outcomes is associated with CKD by comparing pregnancy outcomes of 504 pregnancies in women with CKD to outcomes of 836 low-risk pregnancies in women without CKD. The presence of hypertension, proteinuria (>1 g/d), systemic disease, and CKD stage (at referral) were assessed at baseline. The following outcomes were studied: cesarean section, preterm delivery, and early preterm delivery; small for gestational age (SGA); need for neonatal intensive care unit (NICU); new onset of hypertension; new onset/doubling of proteinuria; CKD stage shift; "general" combined outcome (preterm delivery, NICU, SGA); and "severe" combined outcome (early preterm delivery, NICU, SGA). The risk for adverse outcomes increased across stages (for stage 1 versus stages 4-5: "general" combined outcome, 34.1% versus 90.0%; "severe" combined outcome, 21.4% versus 80.0%; P<0.001). In women with stage 1 CKD, preterm delivery was associated with baseline hypertension (odds ratio [OR], 3.42; 95% confidence interval [95% CI], 1.87 to 6.21), systemic disease (OR, 3.13; 95% CI, 1.51 to 6.50), and proteinuria (OR, 3.69; 95% CI, 1.63 to 8.36). However, stage 1 CKD remained associated with adverse pregnancy outcomes (general combined outcome) in women without baseline hypertension, proteinuria, or systemic disease (OR, 1.88; 95% CI, 1.27 to 2.79). The risk of intrauterine death did not differ between patients and controls. Findings from this prospective study suggest a "baseline risk" for adverse pregnancy-related outcomes linked to CKD.

Indexed as

AdultCase-Control StudiesFemaleHumansLogistic ModelsPregnancyPregnancy ComplicationsPregnancy OutcomeRenal Insufficiency, ChronicYoung AdultCKDclinical nephrologyhypertensionobstetric nephrologyproteinuriarisk factors

Identifiers

PMID25766536
PMCPMC4520166
OpenAlexW2107456031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.